TY - JOUR
T1 - Expanding the phenotype of ASXL3-related syndrome
T2 - A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3
AU - DDD study
AU - Schirwani, Schaida
AU - Albaba, Shadi
AU - Carere, Deanna Alexis
AU - Guillen Sacoto, Maria J.
AU - Milan Zamora, Francisca
AU - Si, Yue
AU - Rabin, Rachel
AU - Pappas, John
AU - Renaud, Deborah L.
AU - Hauser, Natalie
AU - Reid, Evan
AU - Blanchet, Patricia
AU - Foulds, Nichola
AU - Dixit, Abhijit
AU - Fisher, Richard
AU - Armstrong, Ruth
AU - Isidor, Bertrand
AU - Cogne, Benjamin
AU - Schrier Vergano, Samantha
AU - Demirdas, Serwet
AU - Dykzeul, Natalie
AU - Cohen, Julie S.
AU - Grand, Katheryn
AU - Morel, Dayna
AU - Slavotinek, Anne
AU - Albassam, Hessa F.
AU - Naik, Swati
AU - Dean, John
AU - Ragge, Nicola
AU - Cinzia, Costa
AU - Tedesco, Maria Giovanna
AU - Harrison, Rachel E.
AU - Bouman, Arjan
AU - Palen, Emily
AU - Challman, Thomas D.
AU - Willemsen, Marjolein H.
AU - Vogt, Julie
AU - Cunniff, Christopher
AU - Bergstrom, Katherine
AU - Walia, Jagdeep S.
AU - Bruel, Ange Line
AU - Kini, Usha
AU - Alkuraya, Fowzan S.
AU - Slegesky, Valerie
AU - Meeks, Naomi
AU - Girotto, Paula
AU - Johnson, Diana
AU - Newbury-Ecob, Ruth
AU - Ockeloen, Charlotte W.
AU - Prontera, Paolo
N1 - Publisher Copyright:
© 2021 Wiley Periodicals LLC
PY - 2021/11
Y1 - 2021/11
N2 - The study aimed at widening the clinical and genetic spectrum of ASXL3-related syndrome, a neurodevelopmental disorder, caused by truncating variants in the ASXL3 gene. In this international collaborative study, we have undertaken a detailed clinical and molecular analysis of 45 previously unpublished individuals with ASXL3-related syndrome, as well as a review of all previously published individuals. We have reviewed the rather limited functional characterization of pathogenic variants in ASXL3 and discuss current understanding of the consequences of the different ASXL3 variants. In this comprehensive analysis of ASXL3-related syndrome, we define its natural history and clinical evolution occurring with age. We report familial ASXL3 pathogenic variants, characterize the phenotype in mildly affected individuals and discuss nonpenetrance. We also discuss the role of missense variants in ASXL3. We delineate a variable but consistent phenotype. The most characteristic features are neurodevelopmental delay with consistently limited speech, significant neuro-behavioral issues, hypotonia, and feeding difficulties. Distinctive features include downslanting palpebral fissures, hypertelorism, tubular nose with a prominent nasal bridge, and low-hanging columella. The presented data will inform clinical management of individuals with ASXL3-related syndrome and improve interpretation of new ASXL3 sequence variants.
AB - The study aimed at widening the clinical and genetic spectrum of ASXL3-related syndrome, a neurodevelopmental disorder, caused by truncating variants in the ASXL3 gene. In this international collaborative study, we have undertaken a detailed clinical and molecular analysis of 45 previously unpublished individuals with ASXL3-related syndrome, as well as a review of all previously published individuals. We have reviewed the rather limited functional characterization of pathogenic variants in ASXL3 and discuss current understanding of the consequences of the different ASXL3 variants. In this comprehensive analysis of ASXL3-related syndrome, we define its natural history and clinical evolution occurring with age. We report familial ASXL3 pathogenic variants, characterize the phenotype in mildly affected individuals and discuss nonpenetrance. We also discuss the role of missense variants in ASXL3. We delineate a variable but consistent phenotype. The most characteristic features are neurodevelopmental delay with consistently limited speech, significant neuro-behavioral issues, hypotonia, and feeding difficulties. Distinctive features include downslanting palpebral fissures, hypertelorism, tubular nose with a prominent nasal bridge, and low-hanging columella. The presented data will inform clinical management of individuals with ASXL3-related syndrome and improve interpretation of new ASXL3 sequence variants.
KW - ASXL3
KW - ASXL3-related syndrome
KW - BRPS
KW - Bainbridge–Ropers syndrome
KW - intellectual disability
KW - speech impairment
UR - http://www.scopus.com/inward/record.url?scp=85114766945&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.62465
DO - 10.1002/ajmg.a.62465
M3 - Article
AN - SCOPUS:85114766945
SN - 1552-4825
VL - 185
SP - 3446
EP - 3458
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 11
ER -